The Premier Solution for Skin Revitalization
Shattering Limitations, Expanding Treatment Options enlighten® SR combines two highly effective wavelengths with an ultra-short picosecond pulse to introduce an innovative approach to skin revitalization. Improve the appearance of unwanted pigment and aging skin, and enhance overall skin quality and scarring, safely and effectively.
I-VI Fast, Efficient Treatments
Treatment options for various skin types
High Power
50% of the global population reported having at least one pigmentary disorder1
94% of global consumers desired to improve their facial skin and glow2
USD 8.92 billion is the projected size of the global aesthetic lasers market by 2032.3
Real Results with enlighten SR
Before Photos courtesy of Kei Negishi, MD, PhD
After 1 Treatment
Before Photos courtesy of Cutera Clinic
After 3 Treatments
Brilliant, Clearer Skin with PICO Genesis® PICO Genesis delivers intense, non-thermal photomechanical disruption—shattering pigmented lesions on all skin types (I–VI) and triggering a laser-induced shockwave for dermal remodeling. The result: brighter, more uniform skin in 2–3 treatments.
B.
A.
A. Selectively shatter pigmentary issues with highly effective laser wavelengths (532 nm / 1064 nm) B. Deliver non-thermal, laser induced shockwaves for dermal disruption and remodelling (1064 nm)
B.
Renewed Skin with PICO Genesis® FX Enhance skin revitalization with a 1064 nm fractional approach for scars and skin quality on types II–V. The Micro Lens Array (MLA) creates precise micro-wounds in the epidermis and dermis while leaving surrounding tissue intact for faster healing.
A. Vacuole formation immediately post-treatment B. 48 hrs post-treatment: Dermal inflammation initiates a healing response, boosting collagen and elastin production.
A
B
Real Results with PICO Genesis FX
Before Photos courtesy of Revere Clinic
After 3 Treatments
Individual results may vary.
Before Courtesy of Woraphong Manuskiatti, MD
After 1 Treatment
Technical Specifications Wavelength
532 nm
1064 nm
Pulse Energy
300 mJ
500 mJ
Pulse Duration
750 ps
750 ps
Spot Size
2 mm - 8 mm
2 mm - 8 mm
Rep Rate
Single Shot to 10 Hz
Single Shot to 10 Hz
Dimensions
50 cm W x 91 cm H x 84 cm D
MLA Technical Specifications Wavelength
1064 nm
Spot Size
<200 μm
Pitch
0.5 mm
References: 1 Kerob D, et al. Pigmentary disorders, prevalence, impact on quality of life and social stigmatization: Results of the first large international survey. J Am Acad Dermatol. 2024;91(3):AB280. 2 Humphrey S, et al. Defining Skin Quality: Clinical Relevance, Terminology, and Assessment. Dermatol Surg. 2021;47(7):974-981. doi:10.1097/DSS.0000000000003079 3 Pawar S. Global Aesthetic Cosmetic Lasers Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032. Marietta (GA): Data Bridge Market Research; 2024. Available from: https://www.databridgemarketresearch.com/ reports/global-aestheticcosmetic-lasers-market Indications for Use: The enlighten SR laser system is intended for use in aesthetic and cosmetic applications in the medical specialties of dermatology and plastic surgery. 1064 nm: The 1064 nm wavelength of the enlighten SR laser system is indicated for: Treatment of benign pigmented lesions on patients with all skin types (Fitzpatrick I-VI); tattoo removal for dark colored tattoo inks and for multicolored tattoos containing dark colored tattoo inks on patients with all skin types (Fitzpatrick I-VI); and treatment of acne scars on patients with Fitzpatrick skin types II-V when used with the Micro Lens Array handpiece attachment 532 nm: The 532 nm wavelength of the enlighten SR laser system is indicated for: Treatment of benign pigmented lesions on patients with Fitzpatrick skin types I-IV; tattoo removal for lighter colored tattoo inks, including red and yellow inks, on patients with Fitzpatrick skin types I-III. (i) 532 nm (Health Canada): The 532 nm wavelength of the enlighten SR laser system is indicated for: Treatment of benign pigmented lesions on patients with Fitzpatrick skin types I-III; tattoo removal for lighter colored tattoo inks, including red and yellow inks, on patients with Fitzpatrick skin types I-III. Contraindications: Pregnant patients; Patients undergoing treatment for skin cancer. Warnings: Do not treat or treat over dysplastic nevi or questionable pigmented lesions. Only benign pigmented lesions are treatable. Accurate pre-operative diagnosis is very important to prevent treatments on malignant lesions. Precautions: Current medications (both routine and occasional use); Accutane - do not treat if taken in the last 6 months; Gold Therapy - may cause blue-gray discoloration; Photosensitizing drugs (Tetracycline, etc) - perform test spots and adjust parameters accordingly; Anticoagulants - may increase risk of purpura or bruising; Bleeding disorders; Vitiligo or history of pigmentary disorders, particularly tendency for hyper- or hypopigmentation; Herpes - heat from the treatment could induce a flare-up; pretreatment with an antiviral may be indicated; Wound infections; Open lesions - treatments should only be performed on intact, healthy skin; History of coagulopathies; History of keloid or hypertrophic scarring; Diabetes - may impede wound healing; History of seizure disorders due to light.
©2026 Cutera, Inc. All rights reserved. AP2317 rD (09/26)
About Cutera Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera strives to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. Cutera, Inc. World Headquarters | 3240 Bayshore Boulevard, Brisbane, California 94005 USA 888-4-CUTERA or 415-657-5500 | info@cutera.com | cutera.com